Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Profound Medical Corp. before investing.

In this article, we go over a few key elements for understanding Profound Medical Corp.’s stock price such as:

• Profound Medical Corp.’s current stock price and volume
• Why Profound Medical Corp.’s stock price changed recently
• Upgrades and downgrades for PROF from analysts
• PROF’s stock price momentum as measured by its relative strength

About Profound Medical Corp. (PROF)

Before we jump into Profound Medical Corp.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. The company’s lead product TULSA-PRO system combines magnetic resonance imaging (MRI), robotically driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. It also provides Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. Profound Medical Corp. is headquartered in Mississauga, Canada.

Want to learn more about Profound Medical Corp.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Profound Medical Corp..

Profound Medical Corp.’s Stock Price as of Market Close

As of January 30, 2026, 4:00 PM, CST, Profound Medical Corp.’s stock price was $7.500.

Profound Medical Corp. is up 0.27% from its previous closing price of $7.480.

During the last market session, Profound Medical Corp.’s stock traded between $7.220 and $7.590. Currently, there are approximately 30.10 million shares outstanding for Profound Medical Corp..

Profound Medical Corp.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Profound Medical Corp. Stock Price History

Profound Medical Corp.’s (PROF) price is currently down 4.7% so far this month.

During the month of January, Profound Medical Corp.’s stock price has reached a high of $8.950 and a low of $7.205.

Over the last year, Profound Medical Corp. has hit prices as high as $8.950 and as low as $3.760. Year to date, Profound Medical Corp.’s stock is down 4.7%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Profound Medical Corp. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of January 30, 2026, there was 1 analyst who downgraded Profound Medical Corp.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Profound Medical Corp.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Profound Medical Corp.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Profound Medical Corp.’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Profound Medical Corp. (PROF) by visiting AAII Stock Evaluator.

Relative Price Strength of Profound Medical Corp.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of January 30, 2026, Profound Medical Corp. has a weighted four-quarter relative price strength of 5.32%, which translates to a Momentum Score of 69 and is considered to be Strong.

Want to learn more about how Profound Medical Corp. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Profound Medical Corp. Stock Price: Bottom Line

As of January 30, 2026, Profound Medical Corp.’s stock price is $7.500, which is up 0.27% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Profound Medical Corp. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.